Strong growth and solid profits in 2008, but considerable reduction in incoming orders in 2009 A strong growth in net sales and a net profit at the same high level as the previous year are the key features of the 2008 business year for Endress+Hauser. The Group has created numerous jobs worldwide and has made […]
Symyx Technologies, Inc. has announced the launch of the Symyx Contract Development and Manufacturing Organisation (CDMO). The Symyx CDMO (https://www.symyx.com/CDMO) helps biopharmaceutical companies move promising drug candidates to clinical trials faster and more reliably with integrated formulation development, and preclinical and CGMP fill/finish manufacturing. “After discovery, the next critical milestone in drug development is getting […]
SALES FOR 1st HALF YEAR 2008-2009 : GOOD SECOND QUARTER: + 39 % BUT GROWTH FOR FIRST HALF LOWER THAN FORECAST Toulouse, April 30, 2009 – Alpha M.O.S., (Euronext Paris, compartment C, ISIN : FR0000062804-ALM) world leader in the manufacture of electronic noses and tongues for industrial applications, generated sales of € 2,626 million during […]
SAN DIEGO–SEQUENOM, Inc. (NASDAQ: SQNM) today announced that as a result of the continuing weak outlook in 2009 for capital equipment sales, particularly in the USA, the company has implemented cost cutting initiatives in the Genetic Analysis (GA) business to ensure the unit remains financially strong and approaches cash flow breakeven. These measures are expected […]
Leader in Microscale, Parallel Experimentation and Scientific Informatics Offers Integrated Contract Formulation Development and CGMP Fill and Finish Manufacturing SUNNYVALE, CA–Apr 22, 2009 — Symyx Technologies, Inc. (NasdaqGS:SMMX – News) today announced the launch of the Symyx Contract Development and Manufacturing Organization (CDMO). The Symyx CDMO helps biopharmaceutical companies move promising drug candidates to clinical […]
FREMONT, Calif.–WaferGen Bio-systems, Inc. (OTCBB: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, announced that on Friday, March 27, it filed with the Securities and Exchange Commission its Annual Report on Form 10-K for the fiscal year ended December 31, 2008. Complete financial results for our 2008 […]
Wetzlar, Germany. For the first time in its history, Leica Microsystems’ annual sales volume for 2008 exceeded the billion US dollar mark, reports the international high-tech microscope and scientific instrument manufacturer and distributor, headquartered in Wetzlar. “Over the last two years, we have seen a dramatic increase in the demand for our products throughout the […]
FOSS A/S increased turnover to EUR 197 million and EBIT to EUR 30 million – both figures are a record for the company. The company will emerge stronger after the economic crisis thanks to ongoing introduction of groundbreaking innovative products for improvement of food quality. FOSS turnover rose in 2008 to EUR 197 million, equal […]
Unique, Fluorescent Nanocrystal Technology to Combat $1 Trillion in Annual Losses by Global Manufacturers CARLSBAD, Calif. & SAN FRANCISCO–Life Technologies Corporation (NASDAQ: LIFE), and Nanosys, Inc. today announced a cross-licensing agreement to share rights to an intellectual property estate related to fluorescent nanocrystals (also known as quantum dots). New products developed as a result of […]
YOKOHAMA, Japan–Feb. 24, 2009– Bruker Corporation (NASDAQ: BRKR) announced the opening of its expanded, state-of-the-art multi-technology applications and demonstration laboratory, which is co-located with Bruker’s R&D and manufacturing facility for X-ray analysis systems in Yokohama. Yesterday, more than 150 customers, collaborators and business partners witnessed the ribbon-cutting ceremony for Bruker’s expanded 3,000 square-meter Yokohama facility, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
